Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents
Jarrad M Altimari1, Samantha C Hockey, Helena I Boshoff
1Institute for Frontier Materials, and the Strategic Research Centre for Chemistry & Biotechnology, Deakin University, Waurn Ponds Campus, Geelong, Victoria, 3216 (Australia).
None:
Tuberculosis (TB) remains a pressing unmet medical need, particularly with the emergence of multidrug-resistant and extensively drug-resistant tuberculosis. Here, a series of 1,4-substituted-1,2,3-triazoles have been synthesized and evaluated as potential antitubercular agents. These compounds were assembled via click chemistry in high crude purity and in moderate to high yield. Of the compounds tested, 12 compounds showed promising antitubercular activity with six possessing minimum inhibitory concentration (MIC) values <10 microg mL(-1) , and total selectivity for Mycobacterium tuberculosis (Mtb) growth inhibition. A second set of 21 compounds bearing variations on ring C were synthesized and evaluated. This second library gave an additional six compounds displaying MIC values ≤10 microg mL(-1) and total selectivity for Mtb growth inhibition. These compounds serve as an excellent starting point for further development of antitubercular therapies.
Related Concept Videos
Anthelminthic Agents
Antifungal Agents
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Antihypertensive Drugs: Thiazide-Class Diuretics
Diazonium Group Substitution: –OH and –H


